Why Pfizer Stock Tumbled on Tuesday
Source: Motley Fool
2026-04-07 16:31:18 ET
On the second trading day of the week, Pfizer (NYSE: PFE) was a laggard on the stock exchange. An analyst reiterated his bearish view of the stock, and more than a few investors were obviously convinced by the argument. That pushed the shares down by more than 2% that market session.
The pundit behind the new Pfizer note was RBC Capital's Trung Huynh. Before market open, he published an update centered on his underperform (sell, in other words) recommendation and $25 per share price target.
Image source: Getty Images.
Pfizer Inc.
NASDAQ: PFE
PFE Trading
0.07% G/L:
$27.24 Last:
17,103,067 Volume:
$27.21 Open:
PFE Latest News
April 09, 2026 10:00:00 am
Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders
April 08, 2026 12:33:51 pm
Anthropic Inks US$400 Million Deal for AI Biotech Startup Coefficient Bio
PFE Stock Data
$156,612,814,520
5,628,850,476
0.02%
1712
N/A
Pharmaceuticals
Healthcare
US
New York
